Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Aldosteronism Armed Forces Academy of Medical Sciences Outline • Review normal physiology of RAAS system • Review normal physiology of Aldosterone • Primary hyperaldosteronism – Types – Symptoms – Diagnosis – Treatment Normal Structure of Nephron Renin-Angiotensin-Aldosterone System (RAAS) • Controls water reabsorption through the manipulation of sodium reabsorption • Renin release by kidney in response to – – – – Fluid loss Hypotension Low Sodium intake Systemic Vasoconstriction • These factors are sensed by – Baroreceptors (stretch receptors) • Afferent arteriole – Cardiac and arterial baroreceptors – Macula Densa • Early Distal Convoluted Tubule RAAS Physiology Stimulus Angiotensinogen Arterial Constriction Renin Angiotensin II Angiotensin I Sodium Retention Angiotensin Converting Enzyme (ACE) RAAS Physiology • Effects of Angiotensin II – Increases Na Retention • Through direct stimulation of the Proximal Convoluted Tubule (PCT) • Increases Aldosterone secretion – Aldosterone increases sodium retention in corticol collecting tubule • Increased Na retention leads to increased water reabsorption – Direct systemic arterial vasoconstriction • Increased blood pressure RAAS Physiology www.uptodate.com Aldosterone Synthesis • Synthesized in adrenal cortex – Zona glomerulosa Normal Mechanism of Aldosterone Action • Increase number of open sodium channels in the luminal membrane of the principal cells in the cortical collecting tubule – Increased sodium reabsorption • Removal of Na makes lumen electronegative – Potassium is secreted from the cells into the electronegative urine to even out charge Primary Aldosteronism • • • • • • Conn’s syndrome Aldosterone-producing adenoma (30-60%) Bilateral idiopathic Hyperaldosteronism Unilateral adrenal hyperplasia Bilateral macronodular adrenal hyperplasia Familial hyperaldosteronism – Type 1 – Type 2 • Pure aldosterone-producing adrenocortical carcinomas – Ectopic aldosterone-secreting tumors Clinical Features of Primary Aldosteronism • Hypertension • Hypokalemia • Metabolic Alkalosis • Other electrolyte abnormalities • Lack of edema Clinical Features of Primary Aldosteronism: Hypertension • Frequently substantially elevated (> 160 / 100) • Generally resistant to multiple antihypertensive medications • Hypervolemia – Markedly reduces renin secretion • Persistent hypervolemia leads to increased systemic vascular resistance (SVR) • Aldosterone is potent hypertensive agent – Even high normal levels of aldosterone associated with hypertension Clinical Features of Primary Aldosteronism: Hypokalemia • Increased urinary potassium wasting • Serum potassium remains stable for the short term – Aldosterone induced potassium wasting counterbalanced by potassium retaining effect of hypokalemia • Progressive hypokalemia only occurs if another factor is added – Increased aldosterone production – Initiation of diuretic medication Clinical Features of Primary Aldosteronism: Hypokalemia • Patients with primary aldosteronism due to adrenal hyperplasia often do NOT have hypokalemia – Phenomenon not understood • Symptoms of hypokalemia – Mild cases are asymptomatic – Mild elevation of blood pressure – Muscle weakness, cramps, myalgias – ECG changes Clinical Features of Primary Aldosteronism: Other Effects • Metabolic Alkalosis – Due to increased urinary hydrogen ion excretion as a result of aldosterone stimulating Na-H transporter • Mild Hypernatremia – Often between 143 – 147 mEq/L • Hypomagnesemia – Urinary magnesium wasting – Not well understood Hyperaldosteronism and Cardiac Risk • Patients with primary hyperaldosteronism have higher risk of cardiovascular complications then patients with hypertension • Retrospective study of 124 patients with primary aldosteronism to 465 patients with essential hypertension – Two groups matched for age, gender, degree of BP elevation – Higher rates of stroke, myocardial infarction, atrial fibrillation in hyperaldosteronism group Journal American College Cardiology 2005; 45 (8): 1243 Diagnosis of Primary Hyperaldosteronism • First step is to measure Plasma Renin Activity (PRA) and Plasma Renin Concentration (PRC) • PRA and PRC levels affected by diuretic use • PRA and PRC should be LOW in primary aldosteronism • Measure the Plasma Aldosterone Concentration – Calculate PAC/PRA ratio Calculating the PAC/PRA ratio • Measure levels at 0800 • Test can be done while patient takes most of his antihypertensive medications – Must hold spironolactone or eplerenone • Will falsely elevated PRA – ACE inhibitor and ARBs will also affect PRA • Normal value of PAC/PRA 4-10 – Primary aldosteronism average 30-50 Interpreting the PAC/PRA ratio • Primary Aldosteronism: PRA suppressed, PAC increased (usually > 15 ng/dL) – PAC > 20 and PAC/PRA > 30 is 90% specific for primary aldosteronism • Secondary Aldosteronism (renovascular disease): PRA and PAC increased, PAC/PRA < 10 • Other (hypercoritsolism, licorice root ingestion): both PRA and PAC suppressed Establishing Subtype • Adrenal CT – Differentiates adenoma from hyperplasia – Normal adrenal glands does not exclude hyperplasia • Adrenal carcinoma suspected with > 4 cm adrenal mass Confirming Diagnosis • Adrenal vein sampling – Interventional radiologist obtains aldosterone levels from each adrenal vein – Differentiates bilateral from unilateral disease • Indications for adrenal vein sampling – Confirm unilateral disease in anyone considering surgery – When PAC/PRA is abnormal but CT scan normal Treatment of Primary Hyperaldosteronism • Treatment or primary aldosteronism is based on whether aldosterone hypersecretion is – Unilateral – Bilateral • Goal of therapy is to prevent morbidity and mortality associated with – Hypertension – Hypokalemia – Increased cardiovascular risk Treatment of Unilateral Adenoma or Hyperplasia • Surgery: Unilateral adrenalectomy – Unilateral adenoma – Unilateral hyperplasia • Partial adrenalectomy inadequate • Laparoscopic better than open – Shorter hospital stay – Less complications 2008 Endocrine Society Guidelines Post-Op Management of Unilateral Adrenalectomy • Hypertension and hypokalemia controlled medically – Spironolactone or Eplerenone • Plasma aldosterone should be measured the day after surgery to asses for cure • Patients monitored for hyperkalemia as spironolactone, potassium supplements and antihypertensives are discontinued Medical Therapy for Unilateral Adrenal Hyperplasia or Adenoma • Surgical treatment is preferred method • Medical therapy with aldosterone antagonists is effective – 50 point reduction in systolic BP – 30 point reduction in diastolic BP – Increase in serum potassium of > 1.0 mEq/L • Also include low salt diet, regular exercise • No efficacy difference between spironolactone and eplerenone Precautions with Spironolactone • Monitor serum potassium and creatinine frequently during first 6 weeks of therapy • Spironolactone will increase half life of digoxin • Concurrent NSAID use will blunt antihypertensive effects of aldactone • Patients may develop breast tenderness, decreased libido, gynecomastia Treatment of Bilateral Adrenal Hyperplasia • Generally milder disease than adrenal adenoma – Less aldosterone secretion – Less severe hypertension and hypokalemia • Patients should be treated with long term aldosterone antagonist – Aldosterone or Eplerenone – May need thiazide diuretic or ACE inhibitor • Partial Adrenalectomy has been tried and failed Conclusions • Primary hyperaldosteronism is one of the more common causes of hypertension • It often presents as hypertension and hypokalemia • It causes increased cardiovascular morbidity and mortality beyond it’s hypertension • There are many subtypes – Must diagnosis each subtype as treatment varies